RPI US PARTNERS 2019, LP
PFID 805-1073047392
Managed by ROYALTY PHARMA SUB-MANAGER, LLC
Private Equity Fund 3(c)(7)
Gross Asset Value
$1.7B
Min. Investment
$0
Investors
57
First Sale
--
FY End
--
Service Providers
Auditor
ERNST & YOUNG
DUBLIN, Ireland
PCAOB: Registered
Independent: Yes
Custodian
BANK OF AMERICA
NEW YORK, New York, United States
Administrator
SS&C TECHNOLOGIES
WINDSOR, Connecticut, United States
Fund Details
- Fund Type
- Private Equity Fund
- State Organized
- Delaware
- Owned by Adviser
- 92.0%
- Annually Audited
- Yes